HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Experience in the use of ditrastic in the therapy of psoriasis].

Abstract
Forty-six patients suffering from psoriasis have been treated with ditrastic, a new drug for external application, manufactured by Orion, Finland. The drug is manufactured in the form of sticks weighing 2.4 g, containing 1.5 or 3% of dithranol, paraffin, and microcrystalline sulfur. These sticks are applied to psoriatic plaques once daily. The treatment has been effective.
AuthorsI Ia Shakhtmeĭster, O Ia Kaukhova, N A Kunin, E M Shablinskaia, L G Kozyreva
JournalVestnik dermatologii i venerologii (Vestn Dermatol Venerol) Issue 3 Pg. 52-3 ( 1989) ISSN: 0042-4609 [Print] Russia (Federation)
Vernacular TitleOpyt primeneniia ditrastika v terapii psoriaza.
PMID2741547 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Drug Combinations
  • ditrastic
  • Sulfur
  • Paraffin
  • Anthralin
Topics
  • Adolescent
  • Adult
  • Anthralin (therapeutic use)
  • Drug Combinations (therapeutic use)
  • Humans
  • Middle Aged
  • Paraffin (therapeutic use)
  • Psoriasis (drug therapy)
  • Sulfur (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: